Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
Due to limited systemic treatment options, peritoneal carcinomatosis of gastric origin is still associated with a dismal outcome and is claimed a terminal disease. In the past, surgery had not been considered as a potential treatment option. However, there is emerging evidence that in selected patie...
Guardado en:
Autores principales: | Thomas Boerner, Pompiliu Piso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ecb0e7185dfe447bb874fced6406f369 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Implementation of the enhanced
recovery after surgery protocol for patients with peritoneal
carcinomatosis undergoing cytoreductive surgery and
hyperthermic intraperitoneal chemoperfusion
por: Oleksandr Ivanovych Tkachenko, et al.
Publicado: (2021) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
por: Siyuan Qian, et al.
Publicado: (2021) -
Carcinomatosis peritoneal secundaria a carcinoma mucoepidermoide de glándula salival
por: Sánchez P.,Marcelo, et al.
Publicado: (2018) -
Imaging of Gastric Carcinomatosis
por: Raquel Saiz Martínez, et al.
Publicado: (2021) -
CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review
por: Panagiota Berta Panagiotopoulou, et al.
Publicado: (2021)